[Halifax, NS] Get the Scoop: JLABS Canada

Add this event to your calendar:
20/11/2017 17:30 20/11/2017 20:00 America/Halifax [Halifax, NS] Get the Scoop: JLABS Canada Innovacorp Enterprise Centre , , , JLABS @ Toronto false DD/MM/YYYY
November
20
Event

[Halifax, NS] Get the Scoop: JLABS Canada

Innovacorp Enterprise Centre , , ,

November 20, 2017 from 17:30 PM to 20:00 PM (ADT)

$10 - $35



Since opening May 11th, 2016, JLABS @ Toronto now hosts over 48 companies in its space. JLABS @ Toronto offers emerging life science companies modular lab units, office space, shared core laboratory equipment and business facilities. It also links the entrepreneurs with the full breadth of Johnson & Johnson Innovation, including opportunities for funding, third-party services, educational events and R&D experts from medical technology, consumer healthcare product and Janssen pharmaceutical teams.

Come out and learn more about JLABS & how you can be a part of the ecosystem!

After the presentation on Johnson & Johnson Innovation, JLABS, hear a panel discussion on the life science ecosystem in Canada.

Who Should Attend
Life science industry executives, venture capitalists, institutional investors, angel investors, founders, CEOs, and managers of start-ups and other private companies.

Agenda
4:30pm | Registration Opens & Networking
5:00pm | Welcome & JLABS Overview
5:30pm | Q&A
5:45pm | Panel Discussion
6:15pm | Networking Reception
7:00pm | Program Close

Event Partner
World Discoveries


Speakers
Breanne Halyk | Innovation Activation Manager, JLABS Canada, Johnson & Johnson Innovation read bio»
Mohamed Abdolell | CEO, Densitas Inc. read bio»
Kevin Sullivan | CEO, Appili Therapeutics Inc. read bio»
Malcolm Fraser | President & CEO, Innovacorp read bio»

Fees
Free | General Public
Please RSVP online by noon on November 20th so that we can get an accurate headcount.

Location
Innovacorp Enterprise Centre
David O. MacNamara Room
1344 Summer Street
Halifax, NS B3H 0A8


Speaker Biography:
Breanne Halyk | Innovation Activation Manager, JLABS Canada, Johnson & Johnson Innovation
Breanne is the Innovation Activation Manager for Johnson & Johnson Innovation, JLABS in Canada. Breanne supports overall brand building and engagement for Johnson & Johnson Innovation & JLABS throughout Canada, as well as driving awareness of the JLABS value proposition for prospective companies through activation initiatives. Additionally, she is responsible for supporting strategy development of JLABS in Canada and any external engagements in order to advance business objectives. Her role includes coordinating high-quality, diverse and distinctive programming for life science entrepreneurs and developing key partnerships across Canada.

Prior to joining JLABS @ Toronto, Breanne worked for The Princess Margaret Cancer Foundation in Toronto in Business Development & Strategic Initiatives. In that role, Breanne worked on a number of key fundraising events including OneWalk to Conquer Cancer, The Enbridge Ride to Conquer Cancer and Road Hockey to Conquer Cancer, where she was responsible for the planning and execution of numerous high-profile events, internal communications & marketing activities. Breanne holds an Honours Business Degree from the Richard Ivey School of Business at Western University.


Mohamed Abdolell | CEO, Densitas Inc.
Mo Abdolell is a biostatistician with over 20 years experience in modelling data for clinical decision-making. He is an accredited Professional Statistician with the Statistical Society of Canada since 2007. After completing his graduate studies at the University of Toronto he worked at Mount Sinai Hospital, Princess Margaret Hospital, and The Hospital for Sick Children in Toronto. He currently holds a position as Associate Professor in the Department of Diagnostic Radiology at Dalhousie University, and is Affiliated Scientist at the Queen Elizabeth II Health Sciences Centre in Halifax.

Professor Abdolell has a track record of developing innovative applied solutions in the areas of data analytics and medical informatics to address clinical problems. He has been actively engaged in funded research projects with funding to date totalling nearly $3m.


Kevin Sullivan, MBA | CEO, Appili Therapeutics Inc.
Mr. Sullivan has over 21 years of experience working with early stage biotechnology companies and has raised over $37M in private equity and non-dilutive government funding in biotechnology. Most recently he was Chief Executive Officer at DeNovaMed Inc., a biotechnology company focused on development of Gram-negative and Gram-positive antibiotics. Previously, he was Chief Operating Officer at Viron Therapeutics, a biopharmaceutical company developing a novel immunotherapy and recipient of the Prix Galien Award for Biotechnology. At Viron, he and his team completed development of the Company’s lead program through Phase 2 clinical development with Series A and B financing from a syndicate of international venture capital including two pharma-venture participants. He is an active mentor and volunteer advisor for several start-up biotechnology companies. Mr. Sullivan received a BSc in Immunology from Dalhousie University, a Graduate Certificate in Biotechnology from McGill University and an MBA from Western University.


Malcolm Fraser | President and CEO, Innovacorp
Malcolm Fraser is president and CEO of Innovacorp, based in Halifax, Nova Scotia. In this role, Malcolm oversees Innovacorp’s work to find, fund and foster innovative Nova Scotia start-ups that strive to change the world. Malcolm joined Innovacorp in October 2017. He was a leader in Canada’s digital sector for the previous 20 years, earning recognition and awards for innovation, management and community leadership. In 1995, Malcolm started ISL Internet Solutions Ltd., later rebranded as MODE, and grew the company to be Atlantic Canada’s top digital agency. ISL coached many businesses through digital transformation, including Stanfield’s, the Toronto Symphony Orchestra and Tourism Nova Scotia. In 2016, MODE was acquired by Vancouver-based digital marketing agency FCV Interactive, when Malcolm joined the firm’s executive team. The Nova Scotia native has a bachelor of commerce in marketing and economics from Mount Allison University. He is board chair at the Art Gallery of Nova Scotia, research committee chair at Destination Canada, a board member with the Dalhousie Medical Research Foundation and Sobey Art Foundation, and past chair of ITANS, now Digital Nova Scotia.


JLABS @ Toronto

About Johnson & Johnson Innovation, JLABS Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS. About Johnson & Johnson Innovation Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, Johnson & Johnson Innovation | JLABS, Johnson & Johnson Innovation - JJDC, and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com or follow @JNJInnovation.

Event contact


Related content